Cheng Lu

472 total citations
12 papers, 362 citations indexed

About

Cheng Lu is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Cheng Lu has authored 12 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Organic Chemistry. Recurrent topics in Cheng Lu's work include Cancer, Hypoxia, and Metabolism (3 papers), ATP Synthase and ATPases Research (3 papers) and Ubiquitin and proteasome pathways (3 papers). Cheng Lu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), ATP Synthase and ATPases Research (3 papers) and Ubiquitin and proteasome pathways (3 papers). Cheng Lu collaborates with scholars based in China and Taiwan. Cheng Lu's co-authors include Shuhua Zhao, Hong Yang, Yuan Shi, Jia Li, Dan Dai, Huanjie Shao, Zhongqi Li, Hui Xiao, Jia Li and Tingting Song and has published in prestigious journals such as Oncogene, Chemical Communications and Chemistry - A European Journal.

In The Last Decade

Cheng Lu

12 papers receiving 361 citations

Peers

Cheng Lu

MB

CR

OC

IMMUN

PRM

Donglu Wu China

Xiaonan Xi China

Junlong Zhu China

Élisabeth Miot-Noirault France

Linlin Lv China

Yu You China

Jia Shusheng China

Tiziana Tataranni Italy

Jianyang Hu China

Bingling Zhong Macao

Donglu Wu China

Cheng Lu

360 ×1.6

MB

77 ×0.6

CR

46 ×0.9

OC

49 ×1.2

IMMUN

27 ×0.7

PRM

Citations per year, relative to Cheng Lu Cheng Lu (= 1×) peers Donglu Wu

Countries citing papers authored by Cheng Lu

Since Specialization

Citations

This map shows the geographic impact of Cheng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Lu more than expected).

Fields of papers citing papers by Cheng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Lu. The network helps show where Cheng Lu may publish in the future.

Co-authorship network of co-authors of Cheng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Lu. A scholar is included among the top collaborators of Cheng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Lu. Cheng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Lu, Cheng, et al.. (2023). Rational design and development of novel NAE inhibitors for the treatment of pancreatic cancer. Medicinal Chemistry Research. 32(3). 442–474. 2 indexed citations

2.

Liu, Xinghua, et al.. (2022). Visible-light-driven PhSSPh-catalysed regioselective hydroborylation of α,β-unsaturated carbonyl compounds with NHC-boranes. Chemical Communications. 58(60). 8380–8383. 21 indexed citations

3.

Zhao, Shuhua, et al.. (2021). MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway. Cell Death and Disease. 12(1). 18–18. 80 indexed citations

4.

Lü, Peng, et al.. (2021). Design, Synthesis and Biological Evaluation of Coumarin Derivatives as NEDD8 Activating Enzyme Inhibitors in Pancreatic Cancer Cells. Medicinal Chemistry. 18(6). 679–693. 3 indexed citations

5.

Zhao, Shuhua, Xiaohong Zhang, Yuan Shi, et al.. (2020). MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 286–286. 36 indexed citations

6.

Miao, Qi, Dan Dai, Jin Liu, et al.. (2020). AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics. Oncogene. 39(13). 2707–2723. 69 indexed citations

7.

Chen, Dong, Yihong Guo, Yaqiu Chen, et al.. (2020). LncRNA growth arrest‐specific transcript 5 targets miR‐21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN. Cancer Medicine. 9(8). 2846–2858. 30 indexed citations

8.

Lu, Cheng, Bingqing Zhu, Xiaoyü Ma, et al.. (2019). Identification of an Overlooked Halogen‐Bond Synthon and Its Application in Designing Fluorescent Materials. Chemistry - A European Journal. 25(26). 6584–6590. 12 indexed citations

9.

Zhu, Lijuan, et al.. (2019). Design, Synthesis, and Biological Evaluation of 4-amino Substituted 2Hchromen- 2-one Derivatives as an NEDD8 Activating Enzyme Inhibitor in Pancreatic Cancer Cells. Medicinal Chemistry. 16(7). 969–983. 2 indexed citations

10.

Yuan, Lei, et al.. (2018). MicroRNA-1275 targets PKCα to depress proliferation and the invasion of pancreatic cancer cells. Translational Cancer Research. 7(6). 1577–1585. 1 indexed citations

11.

Ning, Chengqing, Cheng Lu, Liang Hu, et al.. (2015). Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2. European Journal of Medicinal Chemistry. 95. 104–115. 32 indexed citations

12.

Lu, Cheng, et al.. (2012). Carvacrol-induced [Ca2+]i rise and apoptosis in human glioblastoma cells. Life Sciences. 90(17-18). 703–711. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact